RedHill Biopharma Ltd. (RDHL)

7.07
0.23 3.20
NASDAQ : Health Technology
Prev Close 7.30
Open 7.32
Day Low/High 7.04 / 7.34
52 Wk Low/High 5.13 / 9.57
Volume 21.02K
Avg Volume 70.60K
Exchange NASDAQ
Shares Outstanding 28.37M
Market Cap 197.10M
EPS -1.70
P/E Ratio 41.65
Div & Yield N.A. (N.A)
3 Small-Caps That Look Like Bargains at Current Trading Levels

3 Small-Caps That Look Like Bargains at Current Trading Levels

The trio consists of BioDelivery Sciences International, Beazer Homes USA and Redhill Biopharma.

RDHL Crosses Above Key Moving Average Level

RDHL Crosses Above Key Moving Average Level

In trading on Monday, shares of Redhill Biopharma Ltd, Ramat Gan crossed above their 200 day moving average of $7.72, changing hands as high as $7.90 per share. Redhill Biopharma Ltd, Ramat Gan shares are currently trading up about 4.5% on the day.

2 Key 'Rules' When Investing in Biotech Stocks

2 Key 'Rules' When Investing in Biotech Stocks

Remembering these 'rules of the road' is vital in this highly volatile space.

How I Invest In Biotech Stocks

How I Invest In Biotech Stocks

Here's two 'rules of the road' when investing in this highly volatile space.

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

TheStreet Quant Rating: D- (Sell)